9th International Patient Symposium on Myeloproliferative Neoplasms

On November 1st, Weill Cornell Medicine and the Cancer Research & Treatment (CR&T) Fund hosted a full-day educational event for over 200 patients and their families to learn about the latest developments in the research and treatment of myeloproliferative neoplasms (MPNs).

Dr. Richard T. Silver, Director Emeritus of the Richard T. Silver, MD, Myeloproliferative Neoplasm (MPN) Center at Weill Cornell Medicine/NewYork-Presbyterian, was joined by several other distinguished physicians and researchers from the world’s most prestigious MPN centers to present the latest research and treatment updates for those with MPNs.

Following opening remarks made by Dr. Silver and Dr. Lewis C. Cantley, Director and Professor of Cancer Biology at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, presenters addressed a number of topics such as MPNs heredity factors, biomarkers and molecular abnormalities, current management of polycythemia vera, as well as drugs in current and future clinical trials. Dr. Koen van Besien, Director of Weill Cornell Medicine and NewYork-Presbyterian’s Bone Marrow and Stem Cell Transplant Program, presented on the current developments in stem cell transplantation as a treatment for MPNs. In the afternoon, patients and their families had the opportunity to ask questions of all the expert speakers during disease-specific Q&A sessions.  

In case you missed the event and would like to review the symposium presentations, visit crt.org.   

Richard T. Silver MD Myeloproliferative Neoplasms Center 525 East 70th St., Starr Pavillion, 3rd Floor New York, NY 10021 SilverMPNCenter@med.cornell.edu